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ABSTRACT  Several  clonal  Leydig  tumor  cell  lines  have  been  established  by  adapting  the 
transplantable  Leydig tumor,  M548OP, to culture.  One of these cell  lines, MLTC-I,  has been 
characterized  with  regard  to  the  gonadotropin-responsive  adenylate  cyclase  system.  The 
binding of 12Sl-labeled human chorionic gonadotropin (hCG) was blocked by excess unlabeled 
hCG and lutropin  (LH)  but not by follitropin,  thyrotropin, or insulin, indicating the presence 
of specific receptors for hCG and LH. Based on the specific binding of hCG to isolated MLTC- 
I  membranes,  the  calculated  dissociation  constant was 1.0 +_. 0.2  x  10  -1°  M.  The  receptors 
appeared identical to those from normal murine Leydig cells when analyzed by SDS PAGE and 
sucrose density gradient centrifugation.  The molecular weight and sedimentation  coefficient 
were 95,000 daltons and 8.5 S, respectively.  MLTC-I  cells responded to hCG by accumulating 
cyclic  AMP  and  producing  progesterone.  Cyclic  AMP  accumulation  was  time-  and  dose- 
dependent with  a maximal  accumulation  occurring  at ~0.2  nM  hCG.  At saturating levels  of 
hCG, cAMP levels  reached a maximum  by 30 min  and then declined very slowly. Adenylate 
cyclase activity  in  membranes prepared from  MLTC-1 cells was stimulated  by hCG,  LH,  NaF, 
cholera toxin, and guanyl-5'-ylimidodiphosphate.  Additionally, choleragen was found to ADP- 
ribosylate a membrane protein of 54,000 daltons. This protein resembles the proposed guanine 
nucleotide regulatory component in both size and choleragen-dependent reactivity. These data 
suggest that  MLTC-I  cells  possess a gonadotropin-responsive  adenylate cyclase system  con- 
sisting of a specific hormone receptor, a regulatory component, and a catalytic subunit. 
A  number of polypeptide hormones mediate their effects on 
target cells  by binding to specific ceil surface receptors  and 
activating  adenylate  cyclasc  (1,  2).  This  process  has  been 
studied in many cells, and investigations have been facilitated 
by the use of cultured ceil lines.  There has been, however, a 
lack of any cell line capable of responding to lutropin (LH) or 
its  analog,  human  chorionic gonadotropin  (hCG),  until  the 
recent independent development of clonal Leydig tumor cell 
lines in this laboratory (3) and in that of Ascoli (4, 5). These 
ceil lines were derived from the transplantable routine Leydig 
tumor designated as M548OP (6). Work in this laboratory has 
produced nine clonal cell lines that bind hormone and dem- 
onstrate  increased  adenosine-Y,5'-monopbosphate  (cAMP) 
production as a  result.  The purpose in developing such ceil 
lines is to study the chain of events initiated by the binding of 
hCG to these cells and to increase our understanding of the 
components  instrumental  in  executing  these  events.  In this 
report I  describe some properties  of one of the nine  Leydig 
70 
tumor cell lines (MLTC-I) as it relates to the gonadotropin- 
responsive adenylate cyclase system. The principal emphasis is 
to demonstrate that MLTC- 1 contains the essential components 
of this hormone-stimulated cyclase system and that the hor- 
mone receptor from MLTC-1 behaves the same as that from 
normal murine Leydig cells when the cross-linked hormone- 
receptor complex is analyzed by either SDS PAGE or sucrose 
density gradient centrifugation. 
MATERIALS  AND  METHODS 
Establishment of Clonal Cell Lines from the 
Leydig Cell Tumor M5480P 
The M548OP  Leydig tumor was initially  obtained from the Papanicolaou 
Cancer Research Institute, Miami, FL After several serial transplants in C57B1/ 
6J male mice. the tumor tissue was frozen in medium 199 (Gibco Laboratories, 
Grand Island BioloBical Co., Grand Island, NY) containing 20% fetal calf serum 
and 10% glycerol and maintained in liquid nitrogen. Immediately before injection, 
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semisterile conditions into  anesthetized mice was  achieved by  subcutaneous 
injection of the tissue just posterior to the rib cage with a fiver biopsy needle. 
CeiLs from tumor-bearing mice were used to establish a cell culture system. 
The tumor was removed from the animal and cut into small pieces that were 
washed in several changes of sterile RPMI-1640 medium (M. A. Bioproducts, 
Walker°rill°, ME)) and teased apart with forceps to liberate the ceils. Cells were 
allowed to settle and attach themselves to the culture dish (25-cm  2 flasks; Falcon 
Plastics, Oxnard, CA). The medium was changed twice during the next several 
days. On the fourth day, the ceils were transferred to a  new flask after being 
detached by forceful pipetting. Henceforth, ceils were grown in 25-cm  2 flasks 
using RPMI medium with 10% fetal calf serum (K. C. Biological, Lenexa, KS), 
50 U of penicillin/mi, and 50/tg of streptomycin/mi under an atmosphere of 5% 
CO2 in air at 37°C. 
Subculturing was achieved by replacement of the medium with a  minimal 
amount  of 0.25%  trypsin  in  Ca2+/Mg  ~+  free  Hanks'  balanced  salt solution 
containing 0.06%  EDTA.  The cells detached from the flask after ~10 rain at 
37°C and were diluted with medium and subdivided into new culture flasks. For 
the purpose of cloning, cells were diluted to an average density of two cells/mi, 
and 1-ml portions were dispensed into the wells of mnltiwell  tissue culture dishes 
(Limbro Scientific, Hamden, CN). Colonies from wells containing only one cell 
initially were propagated as clonal cell lines. Once established, MLTC-I  was 
subcultured weekly at a ratio of 1:5. 
Cross-linking and Analysis of Cross-linked hCG- 
receptor Complexes from ML  TC-'I and Normal 
Testicular Membranes 
Normal murine testicular membranes were isolated as described by Dufau et 
aL (7).  Membranes from MLTC-I  were prepared by scraping cells from their 
culture flasks in PBS and homogenizing them with a Dounce homogenizer. The 
homogenate was centrifuged at 120 g for 20 rain; the supernatant was decanted 
and centrifuged at 27,000 g for 30 rain to yield a crude membrane pellet. These 
and all subsequent centrifugations were done at 4°C unless otherwise noted. The 
membranes were suspended in PBS and 0.5 to I mg of membrane protein was 
incubated in a final vohime of l ml in the presence of 2 x  l0  s disintegrations/ 
rain (dpm) of t2q-hCG (-5 x  10  -m M) and 0.1% bovine serum albumin (BSA) 
for 1 h at 370C. At the end of the incubation, the samples were diluted with 3 ml 
of cold PBS and membranes were collected by centrifugation at 6,700 g for 15 
rain. 
Membrane-bound hormone was cross-linked to its receptor using dlsuccinim- 
idyl sub°rate (DSS) as described by Rebois et at. (8) and was analyzed either by 
SDS PAGE (8, 9) or by sucrose density gradient centrifugation (10). Samples of 
membrane containing 2@)--400 ttg of protein were extracted with 1% Triton X- 
lO0 in 2 mM Tris-HC1, pH 7.4,  for 30 rain at room temperature. After adding 
marker proteins (14C-labeled  ovalbumin and g/obulins), the extracts were placed 
on 5-ml Linear sucrose gradients (5%-20%) made up in 50 mM Tris-HCl, pH 7.4, 
with 0.1% Triton X-100 and centrifuged at 120,000 g for 16 h. Gradients were 
fractionated and ~I  and "C were assayed by gamma and liquid scintillation 
counting, respectively. 
Electrophoretic analysis of the cross-linked hormone-receptor complex was 
carried out using a modification of the procedure described by Rebols et at. (8). 
After sohibilization in 50 mM Tris-HCL pH 6.7, 0.1% glycerol and 1% SDS for 
30  rain at  50°C,  the  sample containing  1-2  mg of membrane  protein  was 
centrifuged for 30 min at 100,000 g in a Beckman airfuge (Becknmn Instruments, 
Inc., Spinco Div., Palo Alto, CA). The resulting superuatant was passed over a 
0.9 X 24 cm Sephadex G-200 colunm equilibrated with 50 mM Tris-HCL pH 6.7, 
and 0.1%  SDS.  The fractions containing the hormone-receptor complex were 
combined and lyophilized  before electrophoresis. 
Hormone Binding to MLTC-1 Cells 
and Membranes 
Binding of hormone to a clonal Leydig tumor cells was performed in culture 
flasks. The growth medium was replaced with 2 ml of fresh medium containing 
ml-hCG. Unlabeled hCG or other hormones were present in some experiments. 
After incubating for I h at 37°C, the medium was removed and the flasks were 
washed twice, each  time with 2  ml of Dnlbeeco's pbosphate-buffered saline 
without Ca  ~+ and Mg  2÷ (PBS) at 4°C. Cells were dissolved using 1 ml of 2 M 
NaOH,  transferred to appropriate robes with an additional 0.5-mi wash, and 
counted in a Beckman model 4000 gamma counter (Beckman Instruments. Inc.). 
Portions were removed for protein estimation. 
Determination of the  dissociation constant  (Kd)  for  hCG  was done  with 
membranes isolated from a crude cell homogenate by centrifugation at 27,000  g 
for 30 rain. The membranes were resuspended and  100-~1 samples comaining 
200-300/tg of protein were incubated in a final volume of 0.4 mi with 0.1% BSA, 
0.01% sodium azide, and various amounts of t2q-hCG. Membranes were incu- 
bated for 14 h  at 37°C before pelleting at room temperature with a Beckman 
microfuge (5  min at  10,000 g) (Beckman Instruments, Inc.). The pellets were 
washed once before measuring bound radioactivity. For estimating the number 
of binding sites, a crude homogenate was used without further purification. The 
incubation was shortened to 2 h and the components of the incubation mixture, 
exclusive of sodium azide, were the same as those described for the first method. 
Membranes were collected by a  filtration technique described previously (11), 
except that Millipore type EG flhers with a 0.2-/xm pore size were used and the 
filters were washed with 0.2% BSA in PBS. Nonspecific binding was determined 
for both cells and membranes by adding 0.2 ~M unlabeled hCG to the incuba- 
tions. 
Choleragen-induced ADP-Ribosylation 
ADP-ribosylation was carried out on a crude membrane fraction isolated in 
the following manner. After removal of the growth medium, cells were scraped 
from flasks in a  small amount of solution containing I  mM EDTA, 0.2 mM 
dithiothreitol (DTT),  and 2  mM Tris-HCL  pH 7.6 (12).  The cells were then 
homogenized with a Dounce homogenizer. The homogenatc was centrifuged at 
400 g for 5 rain and the resulting supernatant was centrifuged at 31,000 g for 20 
rain. The final pellet containing the crude plasma membranes was suspended to 
a concentration of 2-4 mg/mi in a solution of 0.25 M  sucrose, 5 mM MgC12, 1 
mM DTT, and 10 mM Tris-HCl, pH 7.6. A volume of 50/d of this suspension 
was then ADP-ribosylated (13-19) for 3(L45 rain at 31°C with the addition of 10 
~tl of (a-a2P)NAD (10 ttCi), 20 #  of "activated" cholera toxin (4 ~tg) and 20 ftl of 
a  buffer containing 10 mM  ATP,  5  mM  nicotinamide, 5 #tM  NAD,  5 ~tg of 
pyruvate kinase, 75 mM phosphoenol pyruvate, and 250 mM potassium phos- 
phate, pH 7. Choleragen was "activated" by incubating 0.1 mg of the toxin in 
500 p.l of a solution containing 2 nag ovalbumin, 135 mM NaCI, 20 mM DTT, 
and 40 mM HEPES, pH 7.5, for 10 rain at 31°C (12).  After ADP-ribosylation, 
membranes were pelleted in a  Beckman microfuge (10,000  g  for 5  rain). The 
pellets were washed twice with the solution used to suspend the original pellet. 
The final pellet (100-200 v.g) was then solubilized in 50 ~tl of 2% SDS, 5% 2- 
mercaptoethanol, 2% Nonidet P-40, and 10% glycerol for 30 rain at 50°C before 
electrophoresls (9) on a  10% SDS gel with a 3% stacking gel. Methods for gel 
fixation, staining, and destaining were described by Fairbanks et al. (20).  Gels 
were then sliced with a  Bio-Rad gel slicer (Bio-Rad Laboratories, Richmond, 
CA) and the presence of a2p determined with a liquid scintillation  counter. 
Determination of cAMP and Adenylate 
Cyclase Activity 
After removal of the medium, cAMP was extracted from the ceils with 2.0 ml 
of 0.1 M HC1 for 20 rain at 37°C. After lypholization, the residue was dissolved 
in 3 ml of buffer containing 50 mM Tris-HCl, pH 7.4, 8 mM theophyUine and 6 
mM 2-mercaptoethanol and assayed for cAMP by a slight modification (21) of 
the cAMP-binding protein method described by Brown et at. (22). 
The  response of adenylate cyclase to various effectors was determined in 
membranes that were prepared as described above for ADP-ribosylation. Portions 
of the  membrane  suspension containing 65  ~tg of protein  were  assayed for 
adenylate cyclase activity in a final volume of 100 VJ according to the procedure 
of Salomon (23), except that chloride rather than acetate salts of Tris and Mg  2+ 
were used, the concentrations of Mg  2÷ and ATP were doubled, and GTP was 
omitted except for reactions in which choleragen was the effector. In the latter 
instance, choleragen together with NAD and GTP was used to activate MLTC- 
I membranes as previously described (12). 
Other Methods 
Chromosome number was determined by the method of Moorhead et at. (24). 
The  determination of progesterone was done  with a  commercially available 
mdioimmunoassay kit supplied by New England Nuclear (Boston, MA). Samples 
were assayed without performing the extraction or gel filtration steps described 
in the protocol as they were found to be unnecessary. Quantification of protein 
was done by the procedure of Lowry et aL (25) unless interfering substances were 
present.  In such cases, protein was assayed w/th Coomassie Brilliant Blue as 
described by Bradford (26). 
Materials 
The hCG (11,600  IU/mg, CR 119) was provided by R. Canfield (Columbia 
University, through the Center for Population Research of the National Institute 
of Child Health and Human Development). The hCG was iodinated by Meloy 
Industries (Bethesda, MD) as described by Ketelslegers and Catt (27) to a specific 
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Becton,  Dickinson & Co. (Orangeburg,  NY). [a-~P]NAD (200-400 Ci/mmol) 
and (a-a~P)ATP (20-25 Ci/mmol) were obtained from  ICN Nutritional  Biochem- 
icals (Cleveland, OH). [2,8-all]cAMP and [methylJ4C]methylated ovalbumin  and 
globulins were from New England  Nuclear.  Bovine LH (NIH-LH-Bi0, Mr = 
28,260,  1.06 U/mg  relative  to  the  reference  standard  NIH-LH-SI),  bovine 
thyrotropin  (NIH-TSH-B9,  M~ =  28,000, 21.1 IU/mg) and bovine follitropin 
(NIH-FSH-BI, M~ =  33,000, 0.49 IU/mg) were obtained through the Pituitary 
Hormone  Distribution  Program (National Institute of Arthritis, Metabolism, and 
Digestive  Diseases).  Dlsuccinimidy[  suberate (DSS) was purchased from Pierce 
Chemical Co. (Rockford, IL). All other materials were reagent grade. 
RESULTS 
Adaptation of Leydig Tumor Cells to Culture 
with Retention of Hormone Responsiveness 
The Leydig tumors that had been stored in liquid nitrogen 
were  slow  to  grow  in  vivo  and  required  -6  wk  before  the 
tumor became noticeable as a lump on the side of the animals. 
However, after several serial passes of the tumor, transplanta- 
tion could be done at intervals of 2 wk. The survival rate for 
recipients of the tumor was almost 100%, and of the surviving 
mice -80% developed tumors. 
Tumor cells transferred from animals to culture dishes grew 
rapidly and eventually gave rise to nine clonal cell lines. These 
cell lines  were screened for their ability to bind hCG and to 
generate cAMP in response to the hormone. The uncloned cells 
as well as cells of the clonal lines exhibited hCG binding and 
responsiveness  (Table  I).  The  cell  line  that  is  designated  as 
MLTC-I was used for experiments reported here as it was the 
first line available in sufficient quantities. 
Cell Biology of the MLTC-1 Line 
MLTC-  1 as they appear under normal growth conditions are 
shown in  Fig.  1.  When  plated  at  a  density  of  104 cells/cm  2, 
they begin to grow exponentially after a lag period of I to 2 d. 
A doubling of cell number occurred every 35-40 h and the cells 
continued to grow rapidly until reaching a density of -2 x  105 
cells/cm 2 at which point the rate of growth was slowed. It has 
since been found that the lag phase can be virtually eliminated 
by increasing  the serum content of the medium;  however,  in 
the interest of consistency all experiments have been done with 
cells  grown  in  the  medium  used  to  originally  establish  the 
clone.  Chromosome  spreading  showed  that  these  cells  were 
polyploid having 95 ±  4 chromosomes per cell. 
Characteristics of hCG Binding to MLTC-1 Cells 
The binding  of 1251-hCG to MLTC-1  cells was highly spe- 
cific.  Table  II  demonstrates  that  of the  several  peptide  hor- 
mones tested  only hCG  and LH  inhibited  125I-hCG binding. 
The effect of LH was expected as it binds to the same receptors 
on  normal  Leydig  cells  as  hCG  (10).  The  small  amount  of 
inhibition  by thyroid-stimulating hormone (TSH) was attrib- 
uted to contamination of this preparation with LH. Binding of 
hCG to intact cells appeared to be of high affinity. Scatchard 
analysis indicated a Kd of 5.4 ±  0.6 X  10  -E° M (n =  4). Binding 
kinetics with intact ceils should be considered with caution, as 
equilibrium may not be reached due to receptor internalization 
and recycling (28) and receptor number may be altered further 
because hCG is known to induce down regulation of its recep- 
tors (29). 
Binding of hCG to MLTC-1 
Membrane Preparations 
Initial experiments  indicated that binding of very low con- 
centrations  of  hCG  (20  pM)  to  crude  membranes  reached 
TABLE  I 
Binding of hGC to and cAMP Generation  by Cloned and 
Uncloned Leydig Tumor Cells 
cAMP Generation:[: 
Cells  hCG  Bound*  Basal  +hCG 
fmol/10 cells  nmol/lO cells 
Uncloned  22.0 +  1.0  0.05 ±  0.02  2.2 ±  0.1 
MLTC-1  28.3 ±  1.1  0.09 ±  0.03  2.7 ±  0.3 
MLTC-2  39.1  ±  0.1  0.06 ±  0.00  4.24 ±  0.03 
MLTC-3  28.9 ±  0.3  0.19 ±  0.00  3.13 ±  0.06 
MLTC-4  56.0 ±  1.9  0.20 ±  0.07  4.7 ±  0.7 
MLTC-5  56.6 ±  0.7  0.13 ±  0.00  3.4 ±  0.8 
MLTC-6  74.5 ±  2.1  0.3 ±  0A  6.1  ±  1.3 
MLTC-7  48.8 ±  0.I  0.13 ±  0.04  5.0 ±  0.9 
MLTC-8  16.8 ±  0.6  0.38 ±  0.00  2.0 ±  0.3 
MLTC-9  14.0 ±  0.5  0.22 ±  0.00  1.6 ±  0.2 
Uncloned  and cloned  (MLTC-I-MLTC-9)  cells derived  from  the MS6480P 
murine  Leydig  tumor  grown  in  25-cm 2 flasks  (2  X  106 cells/flask)  were 
assayed for  ~2Sl-hCG binding  and  cAMP  production  as described  under 
Materials  and  Methods, Values  are the mean  and range of duplicates  for a 
single experiment. 
* Data represent hCG bound by cells during a 1-h incubation  in the presence 
of  5  x  10  -m  M  ~aSl-hCG. Nonspecific  binding was  <10%  and  has  been 
subtracted. 
:l: Data represent cAMP generated  during a 1-h incubation  in the presence or 
absence of 5 x  10  -I° M  hCG. 
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FIGURE  1  Phase-contrast  micrograph  of MLTC-I  cells. MLTC-I  at a 
density  of  2  x  104  cells/cm 2 were  photographed  4  d  after  subcul- 
turing.  Bar, 100 p,m.  X  115. 
TABLE  II 
Hormone Binding Specificity of ML TC-1 
% Inhibition of 
Hormone  binding 
hCG  100 ±  1 
LH  582  8 
Thyrotropin  6.7 ±  0.6 
Follitropin  I  ±  4 
Insulin  1.3 ±  0.3 
MLTC-1  cells in 25-cm  2 flasks were  incubated  for 1 h with 5 x  10  -1° M  I~51- 
hCG  in  the  absence  and  presence  of  10  -a  M  of  the  indicated  hormone 
(concentration  assumes 100% purity of the hormone) and assayed for bound 
1251-hCG as described  under Materials  and  Methods.  Each value  represents 
the  mean  and  range  of  duplicates  in  a  single  experiment.  100% equals 
displaceable  counts (21,000 -  1,400 =  19,600) out of 21,000 initially bound in 
the presence  of tracer  alone. equilibrium by 2 h  at 37°C. There was no evidence of prote- 
olysis,  as  binding  curves  were  the  same  in  the  presence  or 
absence of phenylmethyl sulfonylfluoride,  a  potent  protease 
inhibitor.  A  Kd of 1.0 +  0.2 X  10  -l° M  (n  --  5)  (Fig.  2)  was 
determined for hCG binding to disrupted cells and was inde- 
pendent of the type of preparation (whole homogenate or crude 
membrane pellet), the length of incubation (2 or 14 h), or the 
means of membrane collection after hormone binding (centrif- 
ugation or fdtration).  In determining receptor number, crude 
homogenates were incubated with increasing concentrations of 
hCG for 2 h  at 37°C and collected by filtration,  a  technique 
found to be as effective as centrifugation at 100,000 g for 1 h, 
suggesting that recovery of membranes was essentially com- 
plete. A value 100 fmol/mg protein was obtained. Based on a 
ratio of 2.1  ×  106 cells/mg crude homogenate protein, it was 
estimated that there were 29,000 +  3,000 binding sites/ceil. As 
a cautionary note, this should be taken as the lowest estimate 
since  homogenization may have  masked  or destroyed some 
receptors. 
Physical Parameters  of the hCG Receptor from 
MLTC-1 Cells 
Bound '25I-hCG was covalently cross-linked to its receptor 
on MLTC-I  membranes  with  DSS  (8).  After extracting  the 
complex with  detergent,  it  was  analyzed by sucrose  density 
gradient centrifugation (Fig. 3A); a  sedimentation coefficient 
of 8.5 S was obtained. This value was identical to that of the 
receptors from normal murine Leydig cells (Fig. 3 B). 
SDS PAGE was also used to determine the respective mo- 
lecular weights of  the cross-linked hormone-receptor complexes 
from normal and tumor cells (Fig. 4). Based on similar exper- 
iments (8), it was concluded that peak I in Fig. 4 represents the 
receptor cross-linked to the intact, cross-linked hCG hormone. 
In  both  normal  Leydig  cells  and  MLTC-1,  the  molecular 
weight of the receptor as determined by subtracting the molec- 
ular weight of the intact hormone (peak III) from the molecular 
weight of the hormone-receptor complex was 95,000.  Peak II 
represents  the  a-subunlt  of hCG  cross-linked  to  the  hCG 
receptor. All of the free a-subunlt and most of the intact, cross- 
linked hormone has been eliminated by gel filtration on Seph- 
adex G-200 before electrophoresis. 
Stimulation of Adenylate Cyclase in MLTC-1 
Cells and Membranes 
The production of cAMP by MLTC-1 in response to hCG 
was time- and concentration-dependent.  In the presence of 5 
X 10  -'° M hCG, the amount of  cAMP within the cells increased 
linearly with time up to 30 min and then declined slowly (Fig. 
5A).  Concentrations  of hCG  as  low  as  10  -n  M  stimulated 
cAMP  production  with  a  maximal  rate  occurring  at  hCG 
concentrations  approximately  an order of magnitude higher 
(Fig. 5 B).  Haft-maximal stimulation occurred at 5 X  10  -n M 
(Fig. 5B) and at 7 x  10  -11 M  when cells were incubated for 
only 30 rain.  Membranes prepared from MLTC-1  cells con- 
tained an adenylate cyclase that was stimulated by hCG and 
LH as well as guanine nucleotides, NaF and "activated chol- 
eragen" (Table  III). Activation of adenylate cyclase by chol- 
eragen also was obtained by incubating the intact cells with 
the toxin (data not shown). 
A substantial increase in the radiolabeling of certain MLTC- 
1 membrane proteins occurred in the presence of choleragen 
when [a-32P]NAD was used as a substrate for the toxin (Fig. 
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FIGURE  2  Binding of hCG  to  membranes isolated from MLTC-1. 
Membranes from MLTC-1 cells and assayed for *2~I-hCG binding 
with increasing concentrations of hCG as described under Materials 
and Methods. Data represent duplicate determinations for specific 
binding in a typical experiment with error bars showing the range. 
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FIGURE  3  Sedimentation  behavior  of  cross-linked  hCG-receptor 
complex from MLTC-1 and normal murine Leydig cells. Membranes 
were incubated with  *2Sl-hCG,  treated with  the cross-linker  DSS, 
and extracted with  1% Triton  X-100  as described under Materials 
and Methods. The extracted cross-linked hCG-receptor complexes 
from  normal  murine  Leydig cells  (A)  and  MLTC-1  (B)  were sedi- 
mented on 5-20%  linear sucrose gradients centrifuged at 120,000 g 
for 16 h. Ovalbumin and globulins were used as markers. 
6). It was presumed, based on the work of other investigators 
(13-19), that the toxin had catalyzed the ADP-ribosylation of 
these  proteins.  The  principal  recipient  of the  ADP-ribosyl 
moiety had a molecular weight of 53,900 _+ 800 as determined 
on the basis of three separate experiments. 
Hormone-stimulated Steroid  Production 
in ML TC-1 
As in the case for the tumor grown in vivo (6),  MLTC-I is 
capable of producing the steroid progesterone in response to 
hCG. The time course of  progesterone production in these cells 
is shown in Fig. 7. When the ceils were exposed to hCG, the 
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Molecular weight determination by SDS PAGE of cross- 
linked hCG-receptor from MLTC-1 and normal murine Leydig cells. 
Membranes were incubated with  12Sl-hCG, treated with the cross- 
linker DSS, and dissolved in SDS as described under Materials and 
Methods. After Sephadex G-200 column chromatography, the cross- 
linked complexes from normal murine Leydig cells (A) and MLTC- 
1  (B)  were analyzed by SDS  PAGE. The mobilities of  proteins of 
known molecular weight (lysozyme, soybean trypsin inhibitor, car- 
bonic anhydrase, ovalbumin, BSA, and phosphorylase B)  are indi- 
cated  (empty circles).  The gel was sliced  into  l-ram  lengths and 
assayed  for  1251 in  a gamma counter.  Peak  I  represents the cross- 
linked complex composed of intact hormone and receptor, peak II 
represents the a-subunit of hCG cross-linked to the receptor, and 
peak III the intact, cross-linked hormone. 
production of progesterone increased linearly with time for 1.5 
h  and  most  of the  steroid  was  released  into  the  medium. 
Testosterone generation was not measured since it is reportedly 
not induced by hormone (6). 
DISCUSSION 
Normal Leydig cells located in situ comprise a very low per- 
centage of the total cell mass of the testis,  and obtaining large 
quantities of highly enriched and viable cells is difficult.  Ex- 
perimental manipulation of the cells in vivo is also difficult as 
the success of an experiment may depend upon injected effec- 
tots reaching their target unaltered and in sufficient quantities 
to be effective,  and isolation  of Leydig cells from the intact 
organ remains a problem. The development of transplantable 
tumors made it possible to isolate large numbers of Leydig cells 
(6,  30),  but  their  viability  is  also  limited.  In  addition,  the 
metabolic state of these tumor cells will be influenced by the 
host and the  age of the  tumor.  Recent  establishment  of the 
hCG/LH-responsive  MLTC lines (3) and other cell lines iso- 
lated from the same tumor by Ascoli (4, 5) circumvents these 
problems.  Although  all  of the  cell  lines  established  in  this 
laboratory  have  receptors  for  hCG  and  produce  cAMP  in 
response to the hormone, only the properties of the MLTC-1 
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cell line are reported. 
The  principal  disadvantage  of this system arises from the 
fact that the tumor cells are different from normal Leydig cells 
in being polyploid. The cells, however, seem to have retained 
the components of the hormone-responsive adenylate cyclase 
system and are capable of translating the hormonal message 
into  the  production  of steroids  as  do  normal  ceils.  Of the 
hormones tested,  only LH and hCG could block the binding 
of 125I-hCG to MLTC-1, suggesting the presence of a receptor 
with specificity for either of these hormones. The experiments 
presented  here,  however,  do  not  rule  out  the  existence  of 
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FIGURE  5  Stimulation  of  cAMP  production  in  MLTC-1  by  hCG. 
Cells were incubated in complete growth medium containing 0.25 
mM  3-isobutyl-l-methyl-xanthene  at 37°C  for  indicated  times  in 
the absence (empty circles) and presence (filled circles) of 5 x  10  -l° 
M  hCG (A). Measurement of the dose response of MLTC-1 to hCG 
was done in the same manner except that the time of incubation 
was  fixed  at  1  h  and  the  concentration  of  hCG  was  varied  as 
indicated (B). The cells then were analyzed for intracellular cAMP 
as described under Materials and  Methods. Values  represent tbe 
mean ±  SD for quadruplicate determinations in a single experiment. 
TABLE III 
Adenylate Cyclase Activity in ML  TC-7 Membranes 
Effector  Activity* 
None  100 ±  10 
hCG  620 =t= 50 
LH  590 ±  50 
NaF  3,260 +  80 
GPP(NH)P  1,360 =1= 50 
Choleragen  1,160 +  70 
Membranes were prepared from  MLTC-1 cells and assayed  for adenylate 
cyclase activity  as described under  Materials and  Methods.  Each assay 
contained 65/~g of protein and was incubated for 10 min at 31°C. Effector 
concentrations  were  10 nM  hCG, 10  nM  LH,  10 mM  NaF, and 50 .aM 
GPP(NH) P. In addition, membranes  were activated with 0.3/~M choleragen, 
2 mM NAD and 100 laM GTP (11) and assayed  for cyclase  activity. Activity 
in membranes treated the same way in the absence  of choleragen was 100 
± 6 pmol/tO rain/rag protein. 
* Adenylate cyclase activity for MLTC-1 membranes is reported as pmol/10 
min/mg protein  and represents the mean ±  SD for triplicates in a single 
experiment. 0.2 
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FIGURE  6  Choleragen-mediated  ADP-ribosylation  of  membranes 
from  MLTC-1,  Membranes were prepared from  MLTC-q  and incu- 
bated with  (a-32P)NAD  in the presence (filled circle) and absence 
(filled square) of "activated" choleragen as described under Mate- 
rials  and  Methods,  The  membranes  were  dissolved  in  SDS  and 
analyzed by  SDS  PAGE.  Incorporation  of 32p was  determined  by 
counting gel  slices  in a  liquid  scintillation  counter and  molecular 
weights were determined relative to the standard proteins  (empty 
circles) as indicated in the legend to Fig. 5. 
receptors  for hormones other  than  LH  or hCG. x Scatchard 
analysis of data  based on isolated  membranes indicated  the 
presence of a single class of hCG receptors with a Kd of 1.0 + 
0.2 ×  10  -1° M which compares favorably with values reported 
for the tumor grown in vivo (6) and for membranes isolated 
from normal rat Leydig cells (10, 31).  Barfing significant loss 
of receptor  binding  activity  during  homogenization,  it  was 
estimated  that intact MLTC-1  bind the equivalent of 29,000 
+  3,000  hCG  molecules/cell.  This  number  is  substantially 
greater than values for either normal Leydig cells isolated from 
testes  by coUagenase dispersion  (32)  or  Leydig tumor cells 
grown in vivo (6). Such a large difference may be the result of 
using different preparations.  The use of a homogenate in this 
case hopefully avoids the difficulties of receptor turn-over that 
are likely to occur when using intact cells (6, 32) for estimation 
of receptor number. 
When Scatchard analysis was used to determine the Ka of 
hCG binding to intact cells, a value of 5.4 + 0.6 x  10  -l° M was 
obtained. This value was similar to that observed by Ascoli (4) 
for his clonal Leydig cell lines but significantly higher than 
values for isolated membranes. Similar discrepancies have been 
reported  for fl-adrenergic receptors  (33,  34).  Data for Kd in 
intact ceils are regarded with caution since a true equilibration 
between  hormone and receptor is unlikely  to be established 
due to the dynamic properties of the living cell.  However, the 
number is  useful  in showing that,  at  least  qualitatively,  the 
intact cell has an apparent high affinity for hormone. 
In terms  of physical  parameters,  the  hCG  receptor  from 
MLTC-1 appears to be identical to that from normal murine 
Leydig cells.  Analysis on SDS PAGE showed that both recep- 
tors have an apparent  molecular weight (Mr)  of 95,000.  Al- 
though  this  is  the  predominant  species,  the  high  molecular 
weight region of the polyacrylamide gels presented in Fig. 4 
suggests that there may be some heterogeneity in the receptor 
as has been shown by Ji and co-workers (35-37) for ovarian 
granulosa cells. On sucrose density gradients, cross-linked hCG 
t MLTC-1 cells accumulated cAMP in response to prostaglandin  El 
but not isoprotercnol (unpublished observations). 
receptors solubilized from normal Leydig and MLTC-I cells 
displayed a  sedimentation coefficient of 8.5  S.  As previously 
suggested for the hCG receptor from rat testes (8),  the deter- 
gent-solubilized murine receptor may exist as a complex which 
can be dissociated by SDS. 
These specific receptors are functional as intact cells accu- 
mulated cAMP in response to hCG. The rate of cAMP accu- 
mulation was time-dependent, reaching a maximum by 30 rain 
and then declining.  This latter effect appears to be a  conse- 
quence of hormone-mediated desensitization (unpublished ob- 
servations).  Hormone-stimulated  cAMP  accumulation  was 
dose dependent with an apparent K~ of 5 x  1011 M. Because a 
true equilibrium may not have been obtained and other proc- 
esses such as desensitization and downregulation are occurring, 
a direct comparison between the Kd for hCG binding to intact 
cells and the K, for hCG-stimulated  cAMP production may 
not be appropriate.  Both processes, however, appear to be of 
high-affinity. 
Stimulation of adenylate cyclase also was observed in iso- 
lated membranes.  The enzyme activity increased in the pres- 
ence of hCG and LH as well as NaF, guanine nucleotides, and 
choleragen. With MLTC-I membranes,  a  sixfold stimulation 
of cyclase  activity was  obtained  with  LH  and  hCG  in  the 
absence of added guanine nucleotides.  This is in contrast to 
the findings of Dufau et al. (38), who observed that adenylate 
cyclase activity in rat testicular membranes was insensitive to 
LH unless guanine nucleotides were added to the assay. Thus 
it appears that MLTC-I membranes contain endogenous gua- 
nine nucleotides. 
It  is  generally  accepted  that  hormone-sensitive  adenylate 
cyclases are composed of at least three components: a hormone 
receptor, a catalytic subunit, and a regulatory component that 
binds guanine nucleotides (2, 39). It has also been shown that 
choleragen activated adenylate cyclase by ADP-ribosylation of 
the regulatory component (13-15).  Thus, stimulation of ade- 
nylate cyclase by guanine nucleotides and choleragen is con- 
sistent  with  the  presence  of  the  regulatory  component  in 
MLTC-1 cells.  Its presence was directly demonstrated by the 
ADP-ribosylation of a 54,000 Mr protein by incubating MLTC- 
1 membranes with choleragen and (a-32P)NAD. In some cells, 
a 42,000 Mr protein is ADP-ribosylated by the toxin (13,  14,  60t 
~4.0 
t 
20  40  60  80 
Time, Min 
FIGURE  7  Stimulation of progesterone production in MLTC-1 cells 
by hCG. Ceils were incubated in serum-free medium at 37°C in an 
atmosphere of 5% CO2  in air in the absence (empty circle, empty 
square) or presence (filled circle, filled square) of 5 x  10  -l° M  hCG. 
Progesterone contained in the cells (empty square, filled square) or 
released  into  the  medium  (empty circle,  filled  circle)  was  deter- 
mined as described under Materials and Methods. Each flask con- 
tained 1,3 :I: 0.1  mg of cell protein. Values represent the mean and 
range for a single experiment. 
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weight (52,000-55,000  Mr) are labeled (15-17);  and, in a  few 
cells, only the higher molecular weight form is present (17,  18). 
Hormone stimulation of normal cells with hCG eventually 
leads to the production of steroid hormones, principally testos- 
terone  (32).  The M548OP  Leydig tumor, however, produces 
progesterone in response to hCG (6).  Testosterone is synthe- 
sised in small quantifies and its synthesis is not induced by 
hormone (6). As expected, the MLTC-1 cell line derived from 
this tumor also produced progesterone in response to hCG. 
Most  of the  steroid  was  released  into  the  medium.  In  the 
absence of hCG,  no detectable progesterone was generated. 
Progesteone also was the end product of hormone stimulation 
in the cell lines developed from the same tumor by Ascoli (4, 
5). 
Experiments  reported  herein  have  been  done  with  cells 
passed <30 times since cloning; and, although no changes have 
been noted, they may occur with continual passage of the cells. 
It is evident, however, that MLTC-1  cultures of low passage 
have retained the components of the adenylate cyclase system. 
It is also evident that the MLTC- 1 line is capable of responding 
to  hCG  by  producing  steroids  although  the  principal  end 
product is progesterone rather than testosterone. Other routine 
Leydig tumor cell lines have been established, but they do not 
respond to gonadotropins (40) and lack hCG receptors. 2 These 
properties are unique to cell lines derived from the M548OP 
Leydig tumor in both this laboratory and that of Ascoli (4, 5) 
and  offer  an  opportunity  to  study  various  aspects  of this 
hormone-responsive system while using the advantages of cell 
culture. 
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